Ginkgo announces public offering of class a common stock

Boston , nov. 16, 2022 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna) ("ginkgo"), which is building the leading platform for cell programing and biosecurity, today announced the sale of shares of  its class a common stock for gross proceeds of approximately $100 million to btig, llc, as the underwriter in the registered public offering of those shares. in connection with this offering, ginkgo has granted the underwriter a 30-day option to purchase up to an additional $15 million of  shares of class a common stock.
DNA Ratings Summary
DNA Quant Ranking